PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map
Entity DossierOrganization

NOVARTIS, INC.

DC · US

Multinational biopharmaceutical company

pharmaceuticals

Tracked direct giving

$0

Tracked donations to candidate

$0

LDA reported lobbying spend

$10,528,000

Connections

14

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

HCRHealth Issues
$15.4M
MMMMedicare/Medicaid
$15.3M
BUDBudget/Appropriations
$15.1M
TAXTaxation/Internal Revenue Code
$15.1M
TRDTrade
$15.1M
CPTCopyright/Patent/Trademark
$15.1M
LBRLabor/Employment
$14.9M
MANManufacturing
$3.8M
VETVeterans
$2.5M
SCIScience
$2.3M

Lobbying Firms Retained

NOVARTIS, INC.$14.9M
FORBES-TATE$150K
TIBER CREEK HEALTH STRATEGIES, INC.$120K
Brownstein Hyatt Farber Schreck$120K
TARPLIN, DOWNS & YOUNG, LLC$60K
TODD STRATEGY GROUP$50K
BGR GOVERNMENT AFFAIRS$20K

Bills Referenced in Lobbying Filings

PBMS. 832march-in

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
Employed byTIBER CREEK HEALTH STRATEGIES, INC.Hired TIBER CREEK HEALTH STRATEGIES, INC. to lobby on PharmaceuticalsSource
Employed byTARPLIN, DOWNS & YOUNG, LLCHired TARPLIN, DOWNS & YOUNG, LLC to lobby on PharmaceuticalsSource
Employed byBrownstein Hyatt Farber SchreckHired BROWNSTEIN HYATT FARBER SCHRECK, LLP to lobby on PBM Reform ActSource
Employed byTODD STRATEGY GROUPHired TODD STRATEGY GROUP to lobby on PBM Reform ActSource
Employed byCorcoran & Associates, Inc. dba Corcoran PartnersHired CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS to lobby on PharmaceuticalsSource
commented_onCenters for Medicare & Medicaid ServicesPublic comment on CMS-2024-0157: Medicare Program: Alternative Payment Model Updates and the Increasing Organ Transplant Access ModelSource
Lobbied forPharmacy Benefit Manager Reform ActLDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000Source
Lobbied forSugar Reform Act (S.832, 118th Congress)LDA filing: lobbied on Sugar Reform Act, period 3rd Quarter (July 1 - Sep 30), reported amount $50,000Source
Employed byFORBES-TATEHired FORBES-TATE to lobby on PharmaceuticalsSource
Lobbied forAction to Delay Effective Date Consistent With Congressionally Enacted MoratoriumLobbied on PBM — matched LDA filing topic to Federal Register rule.Source
Employed byBGR GOVERNMENT AFFAIRSHired BGR GOVERNMENT AFFAIRS to lobby on PharmaceuticalsSource
Lobbied forRights to Federally Funded Inventions and Licensing of Government Owned InventionsLobbied on march-in — matched LDA filing topic to Federal Register rule.Source
Affiliated withSandozSandoz was spun off from Novartis in 2023Source
Affiliated withSandoz Pharma, Ltd.Sandoz was spun off from Novartis in 2023Source